The Effectiveness of Enoant in the Treatment of Bronchitis in Children

Abstract

AbstractWe administered Enoant for the first time in 1993 as a part of a complex treatment for children with recurrent bronchitis (RB). These patients typically have significant disorder of their microbial ecological system, enhancement of lipid peroxidation, and decreased immune responsiveness. The reason for choosing Enoant was a high content of flavonoids, its impact on the microbial biocenosis of the intestine due to active acidity, and finally the absence of alcohol in the medication. To study the effect of Enoant on the microbial ecological system of the intestine and the immune system of children with RB, we observed 142 children aged from 4 to 7 years old. All patients were in the state of remission. The nutritional supplement Enoant was administered 7 ml three times per a day before meals, which equals 56 mg of coloring substance per intake. The course of treatment was 15 days. The control groups received the eubiotics Bifikol diet in combination with phytotherapy. Our research has shown the clinical effectiveness of Enoant, which was accompanied by improvement of bacteriological parameters of intestinal microflora and immune indicators in serum, i.e. the increased activity of complement, lysozyme, phagocytic rates of reaction, concentration of immunoglobulins A and M, the number of T-lymphocytes and reduced level of immunoglobulin E and the CEC.KeywordsMicrobial StructureIntestinal MicrofloraOpportunistic BacteriumSignificant DisorderIntestinal DysbiosisThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.